|
Market Closed -
Other stock markets
|
After hours 07:00:28 am | |||
| 282.01 USD | -3.35% |
|
285.00 | +1.06% |
| Capitalization | 8.18B 7.04B 6.56B 6.11B 11.36B 739B 12.19B 75.43B 29.68B 353B 30.66B 30.04B 1,296B | P/E ratio 2025 * |
42x | P/E ratio 2026 * | 34.3x |
|---|---|---|---|---|---|
| Enterprise value | 7.66B 6.6B 6.15B 5.72B 10.65B 692B 11.42B 70.67B 27.81B 331B 28.73B 28.14B 1,214B | EV / Sales 2025 * |
19.7x | EV / Sales 2026 * | 13x |
| Free-Float |
87.7% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Krystal Biotech, Inc.
| 1 day | +1.06% | ||
| 1 week | +13.30% | ||
| Current month | +14.39% | ||
| 1 month | +16.06% | ||
| 3 months | +46.13% | ||
| 6 months | +90.90% | ||
| Current year | +14.39% |
| 1 week | 257 |  | 295.98 |
| 1 month | 231.68 | | 295.98 |
| Current year | 235.6 | | 295.98 |
| 1 year | 122.8 | | 295.98 |
| 3 years | 70.51 | | 295.98 |
| 5 years | 38.86 | | 295.98 |
| 10 years | 8.03 | | 295.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suma M. Krishnan
COO | Chief Operating Officer | 61 | 2016-04-14 |
| Chief Executive Officer | 61 | 2016-04-14 | |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 2016-04-14 | |
Suma M. Krishnan
BRD | Director/Board Member | 61 | 2016-04-14 |
Daniel Janney
BRD | Director/Board Member | 60 | 2016-10-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.35% | +13.30% | +92.58% | +239.98% | 8.18B | |
| -1.62% | -7.38% | +5.47% | +2.74% | 76.12B | |
| +1.97% | +96.50% | +96.50% | +96.50% | 61.96B | |
| +2.58% | +4.47% | +39.15% | +228.16% | 57.24B | |
| +0.14% | +0.71% | -36.31% | -38.82% | 56.7B | |
| -0.44% | -9.37% | +19.55% | -41.48% | 24.73B | |
| -0.67% | -0.64% | +45.24% | +30.20% | 20.66B | |
| +0.56% | +0.22% | +198.33% | +112.59% | 19.8B | |
| +0.75% | -1.67% | +55.02% | +1,234.75% | 17.14B | |
| -3.01% | +16.24% | +13.20% | -79.50% | 15.38B | |
| Average | +0.92% | +1.21% | +52.87% | +178.51% | 35.79B | |
| Weighted average by Cap. | +1.17% | -0.31% | +38.63% | +113.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 389M 335M 312M 290M 540M 35.14B 580M 3.59B 1.41B 16.8B 1.46B 1.43B 61.63B | 564M 486M 453M 421M 783M 50.94B 840M 5.2B 2.05B 24.35B 2.11B 2.07B 89.34B |
| Net income | 190M 164M 153M 142M 265M 17.21B 284M 1.76B 691M 8.23B 714M 700M 30.18B | 259M 223M 208M 194M 360M 23.44B 387M 2.39B 942M 11.21B 973M 953M 41.11B |
| Net Debt | -516M -444M -414M -385M -716M -46.59B -769M -4.76B -1.87B -22.27B -1.93B -1.89B -81.71B | -859M -740M -690M -641M -1.19B -77.61B -1.28B -7.92B -3.12B -37.1B -3.22B -3.15B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-15 | 282.01 $ | -3.35% | 288,754 |
| 26-01-14 | 291.79 $ | -0.05% | 355,091 |
| 26-01-13 | 291.93 $ | +7.28% | 512,347 |
| 26-01-12 | 272.13 $ | +4.10% | 476,400 |
| 26-01-09 | 261.41 $ | +5.02% | 349,867 |
Delayed Quote Nasdaq, January 15, 2026 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KRYS Stock
Select your edition
All financial news and data tailored to specific country editions
